©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 7, 2021; 27(17): 1936-1942
Published online May 7, 2021. doi: 10.3748/wjg.v27.i17.1936
Published online May 7, 2021. doi: 10.3748/wjg.v27.i17.1936
Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition as harbingers of pancreatic cancer
Maxim S Petrov, School of Medicine, The University of Auckland, Auckland 1142, New Zealand
Author contributions: Petrov MS conceived and wrote the paper.
Conflict-of-interest statement: The author has no conflict of interest.
Corresponding author: Maxim S Petrov, MD, MPH, PhD, Professor, School of Medicine, The University of Auckland, 28 Park Avenue, Auckland 1142, New Zealand.
Received: January 20, 2021
Peer-review started: January 20, 2021
First decision: February 23, 2021
Revised: March 2, 2021
Accepted: April 9, 2021
Article in press: April 9, 2021
Published online: May 7, 2021
Processing time: 99 Days and 1.1 Hours
Peer-review started: January 20, 2021
First decision: February 23, 2021
Revised: March 2, 2021
Accepted: April 9, 2021
Article in press: April 9, 2021
Published online: May 7, 2021
Processing time: 99 Days and 1.1 Hours
Core Tip
Core Tip: Identification of harbingers of pancreatic cancer that are specifically related to the pancreas is necessary to enable cost-effective and achievement-appropriate screening for this disease. Post-pancreatitis diabetes mellitus and excess intra-pancreatic fat deposition are positioned well to serve the purpose.